Oseltamivir Phosphate for Suspension
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20234149
Indications:
1. For the treatment of influenza A and B in adults and children 2 weeks and above (oseltamivir phosphate can effectively treat influenza A and B, but there are not many clinical data on influenza B). Patients should use within 48 hours of the first onset of symptoms.
2. For the prevention of influenza A and B in patients aged 1 year and older.
Administration:
Oseltamivir phosphate can be taken with or without food. However, for some patients, taking the medication with food may improve drug tolerability.
Oseltamivir phosphate for oral suspension should be dispersed in water before use and shaken well before administration.
Specifications:
0.36g (calculated as C16H28N2O4
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.